Skip to main content
SpringerLink
Log in

Pharmacokinetics of flumazenil in fulminant hepatic failure

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Klotz U, Ziegler G, Reimann IW (1984) Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol 27: 115–117

    Google Scholar 

  2. Klotz U, Duka Th, Dorow R, Doenicke A (1985) Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788. Br J Clin Pharmacol 19: 95–98

    Google Scholar 

  3. Klotz U, Ziegler G, Ludwig L, Reimann IW (1985) Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans. J Clin Pharmacol 25: 400–406

    Google Scholar 

  4. Roncari G, Ziegler WH, Guentert TW (1986) Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration. Br J Clin Pharmacol 22: 421–428

    Google Scholar 

  5. Pomier-Layrargues G, Giguère JF, Lavoie J, Willems B, Butterworth RF (1989) Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction. Hepatology 10: 969–972

    Google Scholar 

  6. Janssen U, Walker S, Maier K, Von Gaisberg U, Klotz U (1989) Flumazenil disposition and elimination in cirrhosis. Clin Pharmacol Ther 46: 317–323

    Google Scholar 

  7. Scollo-Lavizzari G, Steinmann E (1985) Reversal of hepatic coma by benzodiazepine antagonist Ro 15-1788. Lancet I: 1324

    Google Scholar 

  8. Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M (1989) Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 97: 44–50

    Google Scholar 

  9. Grimm G, Katzenschlager R, Schneeweiss B et al. (1988) Improvement of hepatic encephalopathy treated with flumazenil. Lancet 11: 1392–1394

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine II, University Hospital Dijkzigt, Rotterdam, The Netherlands

    C. C. D. van der Rijt & S. W. Schalm

  2. Netherlands Institute for Drugs and Doping Research, University of Utrecht, Utrecht, The Netherlands

    R. H. Drost & M. Schramel

Authors
  1. C. C. D. van der Rijt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. H. Drost
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. W. Schalm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Schramel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Rijt, C.C.D., Drost, R.H., Schalm, S.W. et al. Pharmacokinetics of flumazenil in fulminant hepatic failure. Eur J Clin Pharmacol 41, 501 (1991). https://doi.org/10.1007/BF00626380

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00626380

Key words

Search

Navigation